He & She MD Review
Multi-category telehealth platform advertising semaglutide from $139/month, subject to clinical eligibility and confirmation of final terms.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Quick Verdict
Multi-category telehealth platform advertising semaglutide from $139/month, subject to clinical eligibility and confirmation of final terms.
Who it's for: He & She MD may suit adults who prefer a single online-care platform spanning weight management, hormones, longevity, hair growth and sexual health. Its reviewed homepage describes a brief medical quiz followed by licensed-clinician review, with medication shipped if appropriate. The site lists injectable and oral semaglutide and tirzepatide options alongside brand-name pathways, but treatment availability, clinical eligibility and costs can vary. The displayed injectable semaglutide promotion began at $139 per month at review, so readers should confirm whether that amount is introductory, which dose it covers, and whether any services are billed separately.
Bottom line: He & She MD has a broad online treatment menu and a visible semaglutide starting price, but the wide catalog makes an all-in checkout review important. Confirm the exact medication, recurring price, dispensing pharmacy, refill process and cancellation terms before starting. Compounded medications are not FDA-approved finished drugs and should not be treated as interchangeable with FDA-approved products.
- Multiple GLP-1 formats and related care categories listed
- Licensed-clinician review and direct medication delivery described
- Published injectable semaglutide starting promotion
- Published starting price may not reflect all medication formats or doses
- All-in recurring fees and renewal terms require confirmation
- Compounded medications are not FDA-approved finished drugs
Pros & Cons In Detail
He & She MD Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at He & She MD.
| Program / Membership Fee | Included in advertised program price |
| Medication Cost (From) | From $139 – $139/mo |
He & She MD advertised injectable semaglutide from $139/month on the reviewed page. Its page also lists multiple treatment categories; confirm the medication, dose, all-in recurring charge, pharmacy, refill terms and cancellation policy before enrollment.
Who He & She MD Is For
He & She MD may suit adults who prefer a single online-care platform spanning weight management, hormones, longevity, hair growth and sexual health. Its reviewed homepage describes a brief medical quiz followed by licensed-clinician review, with medication shipped if appropriate. The site lists injectable and oral semaglutide and tirzepatide options alongside brand-name pathways, but treatment availability, clinical eligibility and costs can vary. The displayed injectable semaglutide promotion began at $139 per month at review, so readers should confirm whether that amount is introductory, which dose it covers, and whether any services are billed separately.
Adults seeking one telehealth platform for GLP-1 weight management and related hormone, longevity, hair, or sexual-health care.
Signature Programs
- ›Weight-loss medication evaluation
- ›GLP-1 injections and oral options listed
- ›NAD+ and sermorelin programs
- ›Hormone, hair and sexual-health categories
Medication Formulary
The Bottom Line
He & She MD has a broad online treatment menu and a visible semaglutide starting price, but the wide catalog makes an all-in checkout review important. Confirm the exact medication, recurring price, dispensing pharmacy, refill process and cancellation terms before starting. Compounded medications are not FDA-approved finished drugs and should not be treated as interchangeable with FDA-approved products.
With an editor score of 4.0 / 5 across cost, experience, and trust, He & She MD is one of the specialty options in the glp-1 weight loss category we cover.
See how He & She MD compares in our full glp-1 weight loss rankings. Our methodology explains how we score each provider.
Frequently Asked Questions
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss versus 2.4% with placebo at 68 weeks in the STEP 1 trial.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss versus 3.1% with placebo at 72 weeks in SURMOUNT-1.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
